Hepatotoxic effects of tuberculosis therapy.
Preview The recent resurgence of tuberculosis in the United States- fueled in part by its increased incidence among those infected with HIV, substance abusers, and recent immigrants- necessitates a fresh look at tuberculosis therapy. Management is tricky because the first-line antituberculosis drugs can be hepatotoxic, particularly in the presence of underlying liver disease. Patient compliance and close follow-up are essential to achieving a cure while avoiding the pitfalls. Dr Ali describes some of the most commonly used antituberculosis drugs, discusses ways to avoid or minimize hepatotoxicity, and presents a useful algorithm.